(NasdaqGM:URGN), PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed patient enrollment in its Phase 3 UTOPIA clinical trial of UGN-103 (mitomycin) for intravesical solution, a next-generation formulation in […]

CALGARY, Alberta, July 07, 2025 (GLOBE NEWSWIRE) — Mawer Investment Management Ltd. (“Mawer”) announced today that Paul Moroz, CFA, has assumed the role of lead portfolio manager and David Ragan, CFA, has assumed the role of co-manager for the Mawer Global Equity Strategy, effective immediately. Manar Hassan-Agha, CFA, will continue as co-manager. While Christian Deckart,

(CNSX:VRTX.CN),(OTC US:VTECF),(Other OTC:VTECF),(Boerse Frankfurt – Freiverkehr:AA3),(Boerse Frankfurt – Freiverkehr:AA3.F),(Frankfurt:AA3I.F), VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company“) is pleased to announce the finalized sampling plan for the Ambient Noise Tomography (ANT) geophysical survey at its 100%-owned Robinsons River Salt Project, located

(TSX:NFI),(OTC US:NFYEF),(Other OTC:NFYEF),(TSX:NFI-DB),(TSX:NFI.DB), ST. CLOUD, Minn., July 07, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leader in propulsion-agnostic bus and coach mobility solutions, subsidiary New Flyer of America Inc. (New Flyer), has been awarded a contract from Suffolk County Transit for up to 132 buses over the

(Other OTC:LIMX),(OTC US:LIMX), Los Angeles, CA, July 07, 2025 (GLOBE NEWSWIRE) — Limitless X Holdings, Inc. (OTCQB: LIMX), a leading innovator in health, wellness, and performance-driven lifestyle solutions, proudly announces the official launch of Limitless Nootropic Blend Coffee Concentrate, a breakthrough instant coffee product developed by its wholly owned subsidiary, Limitless X, Inc. This product

Baltimore, MD, July 07, 2025 (GLOBE NEWSWIRE) — A released presentation by economic strategist Jim Rickards is drawing fresh attention just as President Trump prepares to introduce his most sweeping economic legislation to date–a bill insiders are calling “The Big Beautiful Bill.” Rather than focus on how much Trump's overhauls might cost, Rickards is asking

(NYSE MKT: VTAK), FORT MILL, S.C., July 07, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced today that it has received a purchase order from Centre Hospitalier Universitaire (CHU) de Rennes. This is the first

(NASDAQ:LENZ), SAN DIEGO and CLERMONT-FERRAND, France, July 07, 2025 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Laboratoires Thea (“Thea”) announced an exclusive license and commercialization agreement for Thea to register and commercialize LNZ100 for the treatment of presbyopia in Canada. LENZ Therapeutics is a pre-commercial stage biopharmaceutical company focused on the development and

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) — For the first time, a study shows a digital assessment can provide a scientific measure of acetylcholine – a key brain chemical whose decline signals the progression of cognitive impairment and Alzheimer's disease. The assessment (here) can be self-administered and completed in about three minutes on internet-connected

(TSE:4519.T), Collaboration to create novel antibody drug candidates using Chugai's proprietary antibody engineering technologies for drug targets identified through Gero's AI-driven human data-first platform Accelerating the creation of innovation by combining Gero's aging-focused target discovery technology with Chugai's drug discovery technologies TOKYO, July 07, 2025 (GLOBE NEWSWIRE) — Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519, hereafter